High S100A16 expression in lung adenocarcinoma, ovarian cancer, cervical cancer and breast cancer were associated with a poor prognosis, whereas high expression in colorectal cancer and oral squamous cell carcinoma was associated with a favorable prognosis [8–11, 19, 20]. Here, S100A16 is linked to ovarian carcinoma.